TEHRAN, Sep. 08 (MNA) – Deputy health minister
has reported on the entry of home-made Hepatitis C drug to the country’s
pharmaceutical market next week noting that it has been produced by
Iranian knowledge-based companies.
“The Sofosbuvir
drug is used to treat hepatitis C cases; previously it was imported from
other countries and priced at $100 per tablet but the indigenous
version will be available at the price of 10 dollars per tablet,” said
Reza Malekzadeh at a press conference on knowledge-based companies
reminding that, “in terms of quality, this drug fully complies with
foreign ones and there is no difference in terms of efficiency or
treatment of the disease.”
He also reported the production of two
other combination drugs to treat hepatitis C in the country adding that
they are currently at laboratory stage and will soon be released. “There
are now drugs that can treat hepatitis C and there exists the
possibility of eradication of the hepatitis C virus in the country in
near future; hepatitis C has a three-month course of treatment and
patients should take one tablet per day for full treatment,” added
Malekzadeh.
Read more... Labels: access to drugs, generic Sovaldi, Iran, Sofosbuvir